相关实验视频

Updated: Jul 12, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

洞察基于RNA的卵巢癌治疗方法

Vahideh Keyvani^1,2,3, Reihaneh Alsadat Mahmoudian^3,4,5, Samaneh Mollazadeh⁶

¹Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Current pharmaceutical design

|November 2, 2023

概括

RNA疗法通过向癌症基因和增强免疫反应,为卵巢癌治疗提供了一个有前途的新策略. 尽管存在诸如RNA降解和输送等挑战,但正在进行的研究表明,有可能改善患者的治疗结果.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物技术是生物技术.

背景情况:

卵巢癌 (OC) 是女性癌症相关死亡的主要原因,通常以治疗耐药性为特征.
目前对OC的治疗策略面临局限性,需要新的方法,如基于RNA的治疗方法.
RNA疗法,包括小干扰RNA (siRNA) 和信使RNA (mRNA) 疫苗,为向的OC治疗提供了一个有希望的途径.

研究的目的:

为提供基于RNA的卵巢癌治疗方法的概述.
突出这些新疗法的潜在好处,挑战和当前研究进展.
讨论纳米基传递系统在增强RNA治疗疗效方面的作用.

主要方法:

对基于RNA的OC治疗方法的临床前和临床研究的审查.
探索针对瘤基因和药物耐药性基因的siRNA介导的基因沉默策略.
研究旨在刺激抗瘤免疫反应的mRNA疫苗.

主要成果:

针对多 (ADP-ribose) 聚合酶1 (PARP1) 基因的siRNA在临床前研究中使OC细胞对PARP抑制剂敏感.
在临床试验中,针对瘤相关抗原的mRNA疫苗在刺激OC患者的免疫反应方面显示出安全性和有效性.
基于纳米的交付平台显示了改善RNA释放和减少非目标效应的潜力.

结论:

基于RNA的疗法通过调节基因表达和利用免疫系统,提供了一种针对性的方法来对抗卵巢癌.
诸如RNA降解,传递效率,非目标效应和免疫性等挑战需要进一步的研究和优化.
持续的临床试验和传递系统的进步对于实现RNA疗法在改善OC患者治疗结果方面的全部潜力至关重要.

关键词:

卵巢癌是发生在卵巢中的癌症.基于RNA的治疗方法这是mRNA疫苗.基于纳米的交付.纳米载体的纳米载体 siRNA 是一个RNA.

更多相关视频

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

相关概念视频

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Types of RNA

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...

The Nucleolus

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...